SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-036341
Filing Date
2022-06-13
Accepted
2022-06-13 16:39:21
Documents
2
Period of Report
2022-06-09

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1580
2 POA DOCUMENT poa.txt EX-24 4660
  Complete submission text file 0001209191-22-036341.txt   7571
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address
Cumbo Alexander (Reporting) CIK: 0001685994 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40489 | Film No.: 221012159

Mailing Address 500 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address 500 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 (978) 501-3026
Verve Therapeutics, Inc. (Issuer) CIK: 0001840574 (see all company filings)

IRS No.: 824800132 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations